A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301

NCT06363760 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Disease
Transfusion-dependent Beta-Thalassemia
Hemoglobinopathies

Interventions

OTHER: Safety and efficacy assessments

Sponsor

Editas Medicine, Inc.